World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
22197
World Ranking
18416
National Ranking
1668

Overview

Donald Milligan is affiliated with the University of Birmingham in the United Kingdom. Their research spans the fields of Medicine, with a particular focus on Hematology, Public Health, Environmental and Occupational Health, and Oncology.

The scientist's primary research topics include:

  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Vascular Tumors and Angiosarcomas

Donald Milligan has published in notable academic venues, including:

  • Journal of Clinical Oncology

A recent publication that illustrates the scope of their work is titled Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations, published in 2024 in the Journal of Clinical Oncology.

Frequent collaborators in their research include:

  • Priyanka Mehta
  • Claire Arnold
  • Adam Rye
  • Robert Cutting
  • Nigel H. Russell

Their work contributes to ongoing advancements in the understanding and treatment of leukemia and related malignancies, integrating clinical and environmental health perspectives within the broader discipline of medicine.

Best Publications

  • Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

    D C Linch;D Winfield;A H Goldstone;D Moir

  • Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

    D Catovsky;S Richards;E Matutes;D Oscier

  • Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study

    Peter J Campbell;Linda M Scott;Georgina Buck;Keith Wheatley

  • A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment†‡

    Alan Kenneth Burnett;Donald Milligan;Archie G. Prentice;Anthony H. Goldstone

  • Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

    Alan Kenneth Burnett;Robert Kerrin Hills;Donald Milligan;Lars Kjeldsen

  • In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.

    Panagiotis D Kottaridis;Donald W Milligan;Rajesh Chopra;Ronjon Chakraverty

  • Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery

    Suparno Chakrabarti;Vivien Mautner;Vivien Mautner;Husam Osman;Husam Osman;Kathryn E Collingham;Kathryn E Collingham

  • Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial.

    Animesh Pardanani;Claire Harrison;Jorge E. Cortes;Francisco Cervantes

  • Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus.

    P Dreger;P Corradini;E Kimby;M Michallet

  • Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia

    Alan Kenneth Burnett;Nigel H. Russell;Robert Kerrin Hills;Jonathan Kell

  • High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.

    Suparno Chakrabarti;Stephen Mackinnon;Rajesh Chopra;Panagiotis D Kottaridis

  • Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

    Alan Kenneth Burnett;Nigel H. Russell;Robert Kerrin Hills;Ann E. Hunter

  • Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

    Ronjon Chakraverty;Karl S Peggs;Rajesh Chopra;Donald W Milligan

  • Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.

    Karl S Peggs;Ann Hunter;Rajesh Chopra;Anne Parker

  • PROGNOSTIC FACTOR ANALYSIS OF THE SURVIVAL OF ELDERLY PATIENTS WITH AML IN THE MRC AML11 AND LRF AML14 TRIALS

    Keith Wheatley;Cassandra l. Brookes;Andrew J. Howman;Anthony H. Goldstone

  • Allogeneic stem-cell transplantation using a reduced- intensity conditioning regimen has the capacity to produce durable remissions and long-term disease- free survival in patients with high-risk acute myeloid leukemia and myelodysplasia

    Sudhir Tauro;Charles Craddock;Karl Peggs;Gulnaz Begum

  • Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

    Emma Morris;Kirsty Thomson;Kirsty Thomson;Charles Craddock;Charles Craddock;Prem Mahendra;Prem Mahendra

  • A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients

    Alan K Burnett;Nigel H Russell;Robert K Hills;Jonathan Kell

  • The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.

    David I Marks;Richard Lush;Jamie Cavenagh;Donald W Milligan

  • Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.

    José A Pérez-Simón;Panagiotis D Kottaridis;Rodrigo Martino;Charles Craddock

Frequent Co-Authors

Nigel H. Russell
Nigel H. Russell University of Nottingham
Alan Kenneth Burnett
Alan Kenneth Burnett University of Glasgow
Robert Kerrin Hills
Robert Kerrin Hills University of Oxford
David C. Linch
David C. Linch University College London
Anthony H. Goldstone
Anthony H. Goldstone University College Hospital
Keith Wheatley
Keith Wheatley University of Birmingham
Charles Craddock
Charles Craddock Queen Elizabeth Hospital Birmingham
Dietger Niederwieser
Dietger Niederwieser Leipzig University
Mary Frances McMullin
Mary Frances McMullin Queen's University Belfast
Karl S. Peggs
Karl S. Peggs University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA offers diverse career pathways beyond the traditional MD. For many students, online education has become an accessible, flexible route into the healthcare sector. Nursing remains a particularly popular choice, allowing for rewarding work and high demand nationwide.

If you’re exploring alternatives or complementary degrees, nursing school online programs offer affordable entry into healthcare, with many curriculum options tailored to different experience levels. Licensed RNs looking to expand their qualifications may benefit from cheap rn to bsn programs, which provide a streamlined path to a more advanced degree and enhanced job prospects.

For non-nursing graduates hoping to transition into the field quickly, direct msn programs online are designed for career changers who want to earn a master’s in nursing efficiently. Those looking to specialize further or enter academia can pursue a phd nursing education online, helping to shape future healthcare policies and train new nurses.

With so many flexible online degrees now available, students interested in medicine have various accessible routes to rewarding health careers across the USA.

Best Scientists Citing Donald Milligan

Trending Scientists